The document presents a method for cancer detection and classification using a deep autoencoder and neural networks applied to gene expression data, which is characterized by high dimensionality and multimodality. It discusses the challenges of current gene expression data, such as the lack of well-documented medical records linked to drug results, while proposing solutions through dimension reduction and feature learning techniques. The findings suggest that the approach offers high accuracy and scalability for multi-classification of various cancer types and potentially aids in drug suggestion.
Related topics: